Copyright © 2022 StrategyHelix Inc. All Rights Reserved.
Global Cannabis Market 2022
According to a report by StrategyHelix, the global cannabis market is set to increase by US$ 70.5 billion during 2022-2028, growing at a CAGR of 21.3% during the forecast period.
The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for cannabis. The global cannabis market is segmented on the basis of product, compound type, application, and region. On the basis of product, the global cannabis market has been segmented into capsules, concentrates, edibles, others. Among these, the concentrates segment was accounted for the highest revenue generator in 2021. By compound type, the global cannabis market has been segmented into balanced THC and CBD, cannabidiol (CBD), tetrahydrocannabinol (THC). The THC segment is estimated to account for the largest share of the global cannabis market. Based on application, the global cannabis market is categorized into medical, recreational. The recreational segment held the largest share of the global cannabis market in 2021 and is anticipated to hold its share during the forecast period. Geographically, the global cannabis market is segmented into North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2021, North America made up the largest share of revenue generated by the cannabis market.
The global cannabis market is highly competitive. The cannabis market is dominated by key players, which are Aphira Inc., Aurora Cannabis Inc., Cannimed Therapeutics Inc., Canopy Growth Corporation, CV sciences Inc., Delta 9 Cannabis Inc., GW Pharmaceuticals plc, Tilray Brands Inc., VIVO Cannabis Inc. Competitive landscape gives a description of the competitive nature of the global cannabis market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the cannabis market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Product: capsules, concentrates, edibles, others
Compound type: balanced THC and CBD, cannabidiol (CBD), tetrahydrocannabinol (THC)
Application: medical, recreational
Region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America
Years considered: this report covers the period 2018 to 2028
Company mentioned: Aphira Inc., Aurora Cannabis Inc., Cannimed Therapeutics Inc., Canopy Growth Corporation, CV sciences Inc., Delta 9 Cannabis Inc., GW Pharmaceuticals plc, Tilray Brands Inc., VIVO Cannabis Inc.
Key Benefits for Stakeholders
– Get a comprehensive picture of the global cannabis market
– Pinpoint growth sectors and trends for investment
Table of Contents
Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Cannabis market overview
Part 3. Market breakdown by product
Part 4. Market breakdown by compound type
– Balanced THC and CBD
– Cannabidiol (CBD)
– Tetrahydrocannabinol (THC)
Part 5. Market breakdown by application
Part 6. Market breakdown by region
– North America
– MEA (Middle East and Africa)
– Latin America
Part 7. Key companies
– Aphira Inc.
– Aurora Cannabis Inc.
– Cannimed Therapeutics Inc.
– Canopy Growth Corporation
– CV sciences Inc.
– Delta 9 Cannabis Inc.
– GW Pharmaceuticals plc
– Tilray Brands, Inc.
– VIVO Cannabis Inc.